The Centre for Cellular and Molecular Platforms (C-CAMP), India’s premier bio-innovation hub has signed a Letter of Intent (LoI) with University of Basel, one of the world’s leading life science clusters and headquarters to globally leading companies in pharma, life science and medical technologies.
The LoI which is the forerunner to the creation of Bangalore-Basel corridor will provide a soft-landing pad for Indian startups and innovators in the life sciences and biotech domains expanding in Swiss markets and vice versa. The focus areas of such an exchange are health-tech, digital health, precision medicine and anti-microbial resistance (AMR) among other life sciences areas. The proposed corridor will intensify the links between these two ecosystems to manifest more effective, accessible and affordable healthcare solutions.
The agreement was signed on the 20th of February, 2020 by Mr. Christian Elias Schneider, Head of Innovation & Entrepreneurship, University of Basel, Switzerland and Dr. Taslimarif Saiyed, CEO & Director of CCAMP, Bangalore in the presence of Mr. Sebastien Hug, CEO & Consul General, Swissnex India.
February 20, 2020